Now Reading: Sunfox Technologies raises $7 Mn in Series A round
-
01
Sunfox Technologies raises $7 Mn in Series A round
Dehradun-based medtech startup Sunfox Technologies has raised $7 million (approx. Rs 67 crore) in a Series A funding round co-led by Ashish Kacholia, Lashit Sanghvi, Alchemy Capital and 3one4 Capital. The company will use the funds to expand its portable cardiac diagnostics platform Spandan across India, grow its team, and invest in R&D and new cardiac technologies, while also building regulatory and commercial capabilities in the US, Europe and Africa.
Sunfox has regulatory approvals in India, Ghana, Kenya, Tanzania and South Africa, and is pursuing clearances in the US and the European Union. The startup claims to have deployed around 60,000 Spandan devices across India, reaching more than 20,000 villages, with its Spandan One platform screening approximately 5 million patients annually. The company, founded in 2016 by Rajat Jain, Arpit Jain, Sabit Rawat, Nitin Chandola and Saurabh Badola, had previously raised Rs 15 crore in a pre-Series A round in August 2024.
Indian Opinion Analysis
Both entrackr and Inc42 reported the funding round identically, leading with the $7 million figure, the investors, and the planned use of funds across geographic expansion and R&D. The coverage is uniform straight reporting with no discernible slant. The key takeaway is the startup's shift from domestic deployment, 60,000 devices in 20,000 villages, toward regulatory and commercial entry into the US, Europe and Africa, where it holds or seeks approvals. Neither source questioned the company's claims or the competitive landscape it faces from players such as AliveCor, Tricog, Agatsa and Cardiotrack.
Coverage: 2 sources, 2 neutral
Sources (2): entrackr.com (neutral report), inc42.com (neutral report)
This brief was synthesised by AI from the 2 sources linked above, so one read covers every framing they carry. Methodology and corrections.
